Betta Pharmaceuticals Co., Ltd., backed by Sequoia Capital China and other investors, has completed an initial public offering on the Shenzhen Stock Exchange's NASDAQ-style ChiNext Board, raising RMB720 million (US$106 million). The pharmaceutical company issued shares at RMB17.57 apiece, at a 22.99 price-to-earning ratio. The company's shares jumped 44% before their trading was halted after […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.